WOAG
WITHDRAWAL OF ATTORNEY GRANTED
25/02/2025
Voltar para busca
Dado oficial do USPTO
SOLVING KIDS' CANCER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SOLVING KIDS' CANCER
ST13
US500000087561693Classe
35, 36, 41, 42, 44, 45
Pedido
87561693
Registro
5436809
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
25/02/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 41, 42, 44, 45
Data de depósito
09/08/2017
Data de registro
03/04/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/12/2024
Última transação
25/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
701
Cadastro oficial
Principal Register
Primeiro uso
13/12/2007
Primeiro uso no comércio
13/12/2007
Código do desenho
4
Tipo de titular
99
Localização do titular
New York, NY
Examinador
RADCLIFF, BRENT
Localização atual
Historical data usage
Titulares e representantes
Titulares
Solving Kids' Cancer, Inc.
Representantes
Solving Kids' Cancer, Inc.
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 41Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
promoting collaboration within the scientificresearchmedical communities in the United States and internationally to achieve advances in the fields of medicinethe treatment of pediatric cancerthe care of pediatric cancer patients; promoting the exchange of information and resources within the scientific research and medical communities in the United States and internationally to achieve advances in the fields of medicinethe treatment of pediatric cancerthe care of pediatric cancer patients; administration and management of research grants; promoting public interest in and awareness of pediatric cancerthe need for research into the treatment of pediatric cancerthe need for funding for research into the treatment of pediatric cancer; promoting the interests of pediatric cancer patients and their families
Classe 36
charitable foundation servicesproviding funding for medical and scientific research in the United States and internationally; accepting and administering monetary charitable contributions to fund medical and scientific research in the United States and internationally; charitable fundraising servicesproviding fund raising activities to support medical and scientific research in the United States and internationally
Classe 41
providing a website featuring on-line non-downloadable videos featuring information in the fields of medicinemedical and scientific researchthe treatment of pediatric cancerthe care of pediatric cancer patients; providing on-line non-downloadable publications in the nature of news articles in the fields of medicinemedical and scientific researchthe treatment of pediatric cancerthe care of pediatric cancer patients; educational servicesproviding podcasts in the fields of medicinemedical and scientific researchthe treatment of pediatric cancerthe care of pediatric cancer patients
Classe 42
providing medical and scientific research information in the fields of pharmaceuticalsclinical trialsthe treatment of pediatric cancerthe care of pediatric cancer patients
Classe 44
providing news and information in the fields of medicinethe treatment of pediatric cancerthe care of pediatric cancer patients
Classe 45
providing patient advocate services in the fields of medicinethe treatment of pediatric cancerthe care of pediatric cancer patients; providing personal support services for pediatric cancer patients and their familiesemotional supportcompanionshiphelp with medical formsproviding information about resources for coping with the emotional effects of a cancer diagnosisproviding information about coping strategies for children with cancer and their familiescoordinating and fostering relationships between families with similar medical needs and experiences
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
25/02/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/12/2024
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/12/2024
ES8R
TEAS SECTION 8 RECEIVED
26/03/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/04/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/01/2018
PUBO
PUBLISHED FOR OPPOSITION
16/01/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/12/2017
ALIE
ASSIGNED TO LIE
06/12/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/11/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
27/11/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/11/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
27/11/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/11/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
27/11/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/11/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
20/11/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/11/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
20/11/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/11/2017
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
14/11/2017
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
14/11/2017
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
14/11/2017
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
14/11/2017
DOCK
ASSIGNED TO EXAMINER
13/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/08/2017
NWAP
NEW APPLICATION ENTERED
12/08/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SOLVING KIDS' CANCER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.